Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies-Reference-Cited by-同舟云学术

Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies

Published:2015-08 Issue:7 Volume:26 Page:785-792
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Rixe Olivier,Puzanov Igor,LoRusso Patricia M.,Cohen Roger B.,Morris John C.,Olowokure Olugbenga O.,Yin Jian Y.,Doroumian Séverine,Shen Liji,Olszanski Anthony J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference26 articles.

1. . Preclinical antitumor activity of cabazitaxel, a semisynthetic taxane active in taxane-resistant tumors.;Vrignaud;Clin Cancer Res,2013

2. Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors An update on the preclinical development of cabazitaxel.;Semiond;Cancer Chemother Pharmacol,2013

3. . Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.;de Bono;Lancet,2010

4. Gemcitabine: preclinical pharmacology and mechanisms of action.;Plunkett;Semin Oncol,1996

5. S-phase specificity of cell killing by docetaxel (Taxotere) in synchronised HeLa cells.;Hennequin;Br J Cancer,1995

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early investigational tubulin inhibitors as novel cancer therapeutics;Expert Opinion on Investigational Drugs;2016-05-30

2. Cationic Supramolecular Vesicular Aggregates for Pulmonary Tissue Selective Delivery in Anticancer Therapy;ChemMedChem;2016-03-08